Applying the risk of bias tool in a systematic review of combination long-acting beta-agonists and inhaled corticosteroids for persistent asthma.
<h4>Background</h4>The Risk of Bias (RoB) tool is used to assess internal validity of randomized controlled trials (RCTs). Our objectives were to: 1) evaluate inter-rater agreement of the RoB tool; 2) determine the time to access supplemental study information; 3) compare the RoB tool wi...
Saved in:
| Main Authors: | Lisa Hartling, Kenneth Bond, Ben Vandermeer, Jennifer Seida, Donna M Dryden, Brian H Rowe |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2011-02-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0017242&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Number 5: Inhaled Corticosteroids in Asthma
by: Richard Leigh
Published: (2001-01-01) -
Erratum to “ADRB2 Arg16Gly Polymorphism and Pulmonary Function Response of Inhaled Corticosteroids plus Long-Acting Beta Agonists for Asthma Treatment: A Systematic Review and Meta-Analysis”
by: Xi Wang, et al.
Published: (2018-01-01) -
Canadian Thoracic Society Asthma Committee Commentary on Long-Acting Beta-2 Agonist Use for Asthma in Canada
by: M Diane Lougheed, et al.
Published: (2010-01-01) -
Perceptions, practices, and experiences of asthma patients and community pharmacists on short-acting beta-2 agonists inhaler use: A qualitative study
by: Rabia Hussain, et al.
Published: (2025-12-01) -
Association of Frequent Short-Acting Beta-Agonist Inhaler Prescriptions with Acute Cardiovascular Events
by: Pfeffer PE, et al.
Published: (2025-07-01)